SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-030546
Filing Date
2024-07-01
Accepted
2024-07-01 08:04:04
Documents
15
Period of Report
2024-07-01
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K ovid-20240701.htm   iXBRL 8-K 29514
2 EX-99.1 ovid20241julexhibit991.htm EX-99.1 24414
6 duallogoa.jpg GRAPHIC 48799
  Complete submission text file 0001628280-24-030546.txt   255229

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ovid-20240701.xsd EX-101.SCH 1898
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ovid-20240701_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ovid-20240701_pre.xml EX-101.PRE 13044
17 EXTRACTED XBRL INSTANCE DOCUMENT ovid-20240701_htm.xml XML 2817
Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38085 | Film No.: 241088227
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)